'Functional unblinding was a major barrier to the approval of psychedelics as medicines to treat the patients who need them most,' said Dr. Andrew Chadeayne, CaaMTech CEO. 'I'm incredibly proud that ...

Psychedelics like psilocybin, MDMA, and ketamine are emerging as promising therapeutic tools for mental health issues. Here's ...

Completed dosing of 115 participants in a bioavailability and bioequivalence (BA/BE) clinical trial in Australia for IHL-42X, an investigational treatment for obstructive sleep apnea in July 2024.

FDA supports CaaMTech's CT-4201 psilocin program for depression, advancing psychedelic therapy and clearing key regulatory ...

The Philomath City Council continued its review of psilocybin regulation options during its regular monthly meeting Tuesday and approved two draft ordinances.

REL-P11 is a proprietary, low-dose, modified-release psilocybin formulationSingle-Ascending Dosing (SAD) study to evaluate safety and ...

LONDON, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced ...

People suffering from major depressive disorder (MDD) and treatment-resistant depression (TRD) often face challenging ...

People are at higher risk of schizophrenia if they indulge in psychedelic drugs, a new study warns. Patients who land in the ER following hallucinogen use have a 21-fold higher risk of developing ...

If the Colorado Springs City Council approves the zoning measure, it would essentially bar the centers from operating in ...

Joe McKay tried everything medicine had to offer for the blinding headaches that began in the months after 9/11, when the ...

However, not everyone with depression will be eligible for this innovative treatment. The study, led by researchers from ...